Physician

Daniel E. Dosoretz, MD

According to 2025 Medicare claims, Daniel Dosoretz, MD (NPI: 1629073200) practices radiation oncology in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is ADVOCATE RADIATION ONCOLOGY, LLC (NPI: 1841753969; TIN: 834138769) and primary practice location at 33952-6720. Dosoretz is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Dosoretz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,164 traditional Medicare patients, billed 14,768 HCPCS/CPT codes, and received $2,639,003 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 48 prescription claims across 28 beneficiaries totaling $28,525 in drug costs. DME data shows 12 claims. Open Payments data shows 4 records totaling $480. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $83,702 to $28,525. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	453	16,658	$2,670,103
2016	523	16,290	$2,600,623
2017	676	24,741	$4,035,079
2018	718	24,350	$3,982,533
2019	485	13,393	$2,472,486
2020	398	14,618	$2,996,035
2021	593	17,401	$3,348,661
2022	963	14,525	$2,474,975
2023	1,046	16,570	$2,810,153
2024	1,164	14,768	$2,639,003

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	152	$83,702
2016	70	150	$155,695
2017	119	249	$169,814
2018	122	261	$205,506
2019	53	84	$58,937
2020	68	122	$123,753
2021	65	152	$123,842
2022	29	49	$27,594
2023	27	45	$6,157
2024	28	48	$28,525

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$147,504

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	383	2,296	$288
G6012	Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev	403	1,711	$187
77427	Radiation treatment management, 5 treatment sessions	275	750	$162
77263	Complex radiation therapy planning	273	307	$140
77336	Continuing radiation therapy consultation per week	284	1,082	$73

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0766	Electrical stimulation device used for cancer treatment, includes all accessories, any type	Y	N/R	12	$147,504

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$480	Siemens Medical Solutions USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel E. Dosoretz, MD?

Tedicare shows public-source Medicare data for Daniel E. Dosoretz, MD (NPI 1629073200), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel E. Dosoretz, MD have ACO affiliation data?

Daniel E. Dosoretz, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Daniel E. Dosoretz, MD?

Daniel E. Dosoretz, MD is linked to ADVOCATE RADIATION ONCOLOGY, LLC (billing NPI 1841753969) in the available physician profile data.

Does Daniel E. Dosoretz, MD have Open Payments data?

Daniel E. Dosoretz, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.